The optimal time of elective percutaneous coronary intervention for stable patients after ST elevation myocardial

Guliz Erdem Yazici1, Murat Erden, Gulten Aydogdu Tacoy

  • 1Cardiology Department, Gazi University Faculty of Medicine, Ankara, Turkey. gulizerdem76@yahoo.com

Angiology
|April 5, 2008
PubMed

Insights

For ST-elevation myocardial infarction (STEMI) patients, early revascularization (within 3 days) shows no significant benefit over late revascularization (>3 days) for angiographic or clinical outcomes. This suggests prompt intervention is not essential for improved results.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • ST-elevation myocardial infarction (STEMI) requires timely reperfusion therapy.
  • The optimal timing for revascularization in the subacute phase remains a subject of investigation.
  • Percutaneous coronary intervention (PCI) is a primary revascularization strategy.

Purpose of the Study:

  • To determine the optimal timing for revascularization in STEMI patients during the subacute phase.
  • To compare early (< or =3 days) versus late (>3 days) revascularization outcomes.
  • To evaluate the impact of revascularization timing on angiographic and clinical results.

Main Methods:

  • Retrospective analysis of 99 STEMI patients treated between 2000 and 2004.
  • Patients categorized into early (< or =3 days) and late (>3 days) revascularization groups based on symptom onset to PCI time.
  • Quantitative coronary angiography used to assess outcomes before and after revascularization.

Main Results:

  • 45 patients in the early group and 54 in the late group were analyzed.
  • No significant differences observed between early and late groups in demographics, thrombus burden, procedural success, or quantitative angiographic parameters.
  • Clinical outcomes were comparable between the two revascularization timing groups.

Conclusions:

  • Delaying PCI in STEMI patients until the subacute phase does not offer discernible advantages in angiographic or clinical outcomes.
  • Early revascularization is not demonstrably superior to later intervention in this patient cohort.
  • Current findings suggest that waiting for a stable phase before PCI may not be necessary.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...